搜索结果

疾病ID:TCMBANKDI003337

疾病名:Infertility

MeSH_Name:Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases

HPO_Name:Abnormality of the genitourinary system

UMLS_Name:Pathologic Function

DO_Name:disease of anatomical entity

疾病类型:phenotype

DisGeNET_Link:C0021359

MeSH_Link:C13; C12

HPO_Link:HP:0000119

UMLS_Link:T046

DO_Link:DOID:7

HERB_ID:-

   疾病对应的植物
ID 拉丁名 药名 药用植物名 功能与主治 来源 药用部位 使用民族
   疾病对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN058205 trans-resveratrol (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; SRT501; AX8004672; DB02709; RP17549; NCGC00017352-05; NCGC00017352-13; NCGC00017352-19; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; 4CN-0696; I06-0437; 3,4',5-Trihydroxy-trans-stilbene; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; s1396; HMS1990H15; SAM001246888; CPD000058206; CU-01000001503-3; BPBio1_000479; NCGC00024003-14; (E)-5-(p-Hydroxystyryl)resorcinol; FT-0082623; Tox21_501111; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 01R360; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Tox21_303376; MLS001055357; NCGC00024003-13; GP5884; A827984; resveratrol; NCGC00017352-09; NCGC00017352-15; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; NCGC00024003-11; D0U3EP; ACN-034773; ST057251; EU-0101111; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; HY-16561; N1848; ACT09778; NCGC00017352-17; BRD-K80738081-001-09-6; KUC104385N; 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; LUKBXSAWLPMMSZ-OWOJBTEDSA-N; STL; MLS001424228; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol; HMS1569F17; Resveratrol, Vetec(TM) reagent grade, 98%; HMS1921N04; IDI1_002152; Resvida; KB-02515; SR-01000000163-10; NCGC00017352-08; AB00052942_31; 3,5,4'-Trihydroxystilbene; trans-Stilbene-3,4',5-triol; Tox21_110257; NCGC00024003-12; trans-3,4′,5-Trihydroxystilbene; trans-3,4',5 - trihydroxystilbene; ZB000650; ZINC6787; DSSTox_RID_78898; NCGC00024003-09; 3fts; BB_NC-2570; SRT-501; ZX-AS004941; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol; BRD-K80738081-001-23-7; trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; NSC327430; LS-2146; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; NCGC00024003-04; DSSTox_CID_11980; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol; Prestwick3_000508; trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard; Resveratrol, European Pharmacopoeia (EP) Reference Standard; NCGC00015894-02; ARONIS24568; STL146386; R 5010; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; AC1L9HIC; BSPBio_003461; REGID_for_CID_445154; C14H12O3; SR-01000000163-11; 501-36-0; C03582; SRT 501; NSC 327430; NSC-327430; Spectrum5_000552; AS-12413; Trans-3,4′ NCGC00024003-06; AKOS005720936; BG01529320; BBC/741; HMS1792H15; NCGC00258925-01; TL8003323; AB00052942-29; SR-01000000163-4; SR-01000000163-16; BSPBio_000435; Opera_ID_586; NC00349; 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-; ZX-AT013797; 375823-41-9; HMS3403H15; 3,4',5-Trihydroxystilbene; HMS2232A18; KSC-10-164; AN-865; LMPK13090005; AJ-08292; OR46018; R0071; CHEMBL165; BRD-K25591257-001-01-2; Resveratrol, E-; BBL028252; NCGC00024003-05; LP01111; UNII-Q369O8926L; CCG-38874; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; MFCD00133799; 2l98; BDBM23926; SGCUT00007; GP2549; Resveratrol, trans-; CC-34242; ST2408097; MLS001076538; AK-39118; HMS1362H15; NCGC00024003-07; ABP000376; SBB055452; NCGC00017352-16; trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Tox21_110257_1; BRD-K80738081-001-06-2; Resveratrol, certified reference material, TraceCERT(R); 3,4',5-Stilbenetriol; MCULE-5678456463; J10118; BSPBio_001114; HMS2052I09; Resveratrol, >=99% (HPLC); CS-1050; SCHEMBL19425; 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol; Resveratol; (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; HMS3263O04; 4jaz; AB0006623; CAS-501-36-0; CCRIS 8952; MLS000069735; trans-3,4',5-trihydroxystilbene; 4qer; Tox21_201374; to_000079; SPECTRUM1502223; BC202036; API0000480; NCGC00017352-10; CHEBI:27881; NCGC00017352-24; SY014849; 3,4',5-trihydroxy-stilbene; NCGC00017352-06; PREVENTION 8 (RESVERATROL); MolPort-002-499-801; (E)-resveratrol; BCPP000091; Prestwick_619; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; SMR000058206; cid_445154; Q369O8926L; Resveratrol, analytical standard; DSSTox_GSID_31980; NCGC00017352-11; AC-727; HMS2096F17; BS0159; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol; BRD-K80738081-001-10-4; NCGC00017352-12; MLS002222231; Resveratrol, natural; Lopac0_001111; BR-39118; CJ-00111; NCGC00017352-07; DTXSID4031980; CR-003; Stilbene, 2f; NCGC00017352-18; NCGC00024003-10; SC-11924; SR-01000000163-3; MLS002207121; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; NCGC00024003-00; HMS3649A20; KS-5047; 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-; NCGC00017352-14; HSDB 7571; NCGC00024003-08; 533C1DA0-4104-42B5-9D32-9265F40857E4; RM-1812; REGID_for_CID_6240; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; BIK9013; NCGC00257465-01; GTPL8741; BG00606847; NCGC00261796-01; CHEBI:45713; SR-01000000163; Resveratrol, synthetic; SR-01000000163-9; Prestwick2_000508; N88795; 3,5,4'-Trihydroxy-trans-stilbene; resveratrol; 1,3-Benzenediol, 5-((1Z)-2-(4-hydroxyphenyl)ethenyl)-; cis-3,5,4'-trihydroxystilbene; AIDS025474; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; SPBio_002356; BPBio1_000479; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Spectrum4_001896; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; EU-0101111; ST057251; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; resveratrol ; KBioSS_000454; 1684AH; Spectrum3_001821; STL; CHEBI:36002; SPBio_001513; IDI1_002152; Prestwick1_000508; 05F9DB2A-D7E6-4063-8E5B-F7842CF74A5E; 3,5,4'-Trihydroxystilbene; 3,4',5-trihydroxy stilbene; (Z)-resveratrol; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; trans-3,4′,5-Trihydroxystilbene; 31100-06-8; 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Cis resveratrol; SRT-501; NSC327430; 3,4′,5-Trihydroxy-trans-stilbene; Spectrum_001148; 5-[(1Z)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00024003-04; Prestwick3_000508; NCGC00015894-02; Z-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00017352-03; SCHEMBL1931746; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; BSPBio_003461; Bio2_000877; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1-; 31100-06-8 (DELETED); Z-Resveratrol; UNII-AUA0K06FSB; 501-36-0; C03582; AKOS025395422; KBio2_004196; KBio3_002965; Prestwick0_000508; NSC 327430; 34092_RIEDEL; KBio3_000848; NCGC00017352-02; Spectrum5_000552; MolPort-003-850-143; NCGC00024003-06; KBio2_005590; SpecPlus_000391; AC1LU7HY; AUA0K06FSB; KBioGR_000454; AIDS-025474; BSPBio_000435; cis-resveratrol; KBio2_006764; KBio2_001628; KBioGR_002457; CHEMBL87333; 3,4',5-Trihydroxystilbene; Lopac-R-5010; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; KBio2_000454; Resveratrol, (Z)-; SGCUT00007; CJ-13797; NCGC00024003-07; Resveratrol (Z)-form [MI]; NCGC00017352-01; I14-7425; DivK1c_006487; MolMap_000045; 3,4',5-Stilbenetriol; Oprea1_727238; Tocris-1418; DB-072954; NCGC00017352-04; BSPBio_001114; BDBM50131698; 434C671; LUKBXSAWLPMMSZ-UPHRSURJSA-; KBio3_000847; CAS-501-36-0; SMP1_000257; 4q93; MLS000069735; cis-5-[2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol; ZINC00006787; (Z)-3,5,4'-trihydroxystilbene; to_000079; SPECTRUM1502223; trans-Resveratrol; R5010_SIGMA; KBio2_003022; 61434-67-1; NCGC00024003-02; NCGC00015894-01; CHEBI:27881; Resveratrol; AC-24235; (E)-resveratrol; Prestwick_619; 5-[2-(4-hydroxyphenyl)vinyl]resorcinol; SMR000058206; TNP00294; Resveratrol, Z-; ZINC12353732; Lopac0_001111; cis-3,4',5-trihydroxystilbene; NCI60_002840; 5-[(E)-2-(4-hydroxyphenyl)vinyl]resorcinol; Bio2_000397; NCGC00024003-00; (Z)-3,4',5-trihydroxystilbene; 3,5-Dihydroxy-4'-methoxystilbene; 3, 5,4'-trihydroxy-trans-stilbene; cis-3,4,5-Trihydroxystilbene; NCGC00024003-08; RM-1812; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; KBioSS_001628; KBio1_001431; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CHEBI:45713; Spectrum2_001497; Prestwick2_000508; 3,5,4'-Trihydroxy-trans-stilbene C14H12O3 228.24 g/mol C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
   疾病对应的靶点
靶点ID 基因名 基因别名 描述
TCMBANKGE012478 DNAL1 C14orf168; CILD16; LC1 dynein axonemal light chain 1
TCMBANKGE011859 CFI AHUS3; ARMD13; C3BINA; C3b-INA; FI; IF; KAF complement factor I
TCMBANKGE002581 PROP1 CPHD2; PROP-1 PROP paired-like homeobox 1
TCMBANKGE008894 NANOS1 EC_Rep1a; NOS-1; NOS1; SPGF12; ZC2HC12A nanos C2HC-type zinc finger 1
TCMBANKGE003821 C9 ARMD15; C9D complement C9
TCMBANKGE013044 GBA2 AD035; NLGase; SPG46 glucosylceramidase beta 2
TCMBANKGE010781 BRCA2 BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD; FANCD1; GLM3; PNCA2; XRCC11 BRCA2 DNA repair associated
TCMBANKGE007721 C5 C5D; C5a; C5b; CPAMD4; ECLZB complement C5
TCMBANKGE013721 LRRC6 CILD19; LRTP; TSLRP; tilB leucine rich repeat containing 6
TCMBANKGE000434 PTGER2 EP2 prostaglandin E receptor 2
TCMBANKGE008421 STUB1 CHIP; HSPABP2; NY-CO-7; SCA48; SCAR16; SDCCAG7; UBOX1 STIP1 homology and U-box containing protein 1
TCMBANKGE008763 IL6ST CD130; CDW130; GP130; HIES4; IL-6RB; sGP130 interleukin 6 signal transducer
TCMBANKGE009149 AK7 AK 7; CFAP75; FAP75; SPGF27 adenylate kinase 7
TCMBANKGE010759 H6PD CORTRD1; G6PDH; GDH; H6PDH hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
TCMBANKGE009021 HLA-DQB1 CELIAC1; HLA-DQB; IDDM1 major histocompatibility complex, class II, DQ beta 1
TCMBANKGE014639 TTC19 2010204O13Rik; MC3DN2 tetratricopeptide repeat domain 19
TCMBANKGE001074 ATM AT1; ATA; ATC; ATD; ATDC; ATE; TEL1; TELO1 ATM serine/threonine kinase
TCMBANKGE000341 RNF216 CAHH; TRIAD3; U7I1; UBCE7IP1; ZIN ring finger protein 216
TCMBANKGE012773 MIF GIF; GLIF; MMIF macrophage migration inhibitory factor
TCMBANKGE008668 ZP1 HEL163; OOMD; OOMD1 zona pellucida glycoprotein 1
TCMBANKGE010749 TSGA10 CEP4L; CT79; SPGF26 testis specific 10
TCMBANKGE000201 ESR1 ER; ESR; ESRA; ESTRR; Era; NR3A1 estrogen receptor 1
TCMBANKGE000168 NR3C1 GCCR; GCR; GCRST; GR; GRL nuclear receptor subfamily 3 group C member 1
TCMBANKGE013153 IL1R2 CD121b; CDw121b; IL-1R-2; IL-1RT-2; IL-1RT2; IL1R2c; IL1RB interleukin 1 receptor type 2
TCMBANKGE000243 LMNA CDCD1; CDDC; CMD1A; CMT2B1; EMD2; FPL; FPLD; FPLD2; HGPS; IDC; LDP1; LFP; LGMD1B; LMN1; LMNC; LMNL1; MADA; PRO1 lamin A/C
TCMBANKGE006708 RPGR COD1; CORDX1; CRD; PCDX; RP15; RP3; XLRP3; orf15 retinitis pigmentosa GTPase regulator
TCMBANKGE014837 LEPR CD295; LEP-R; LEPRD; OB-R; OBR leptin receptor
TCMBANKGE008329 HSD17B3 EDH17B3; SDR12C2 hydroxysteroid 17-beta dehydrogenase 3
TCMBANKGE003789 HLA-DQA1 CELIAC1; DQ-A1; DQA1; HLA-DQA major histocompatibility complex, class II, DQ alpha 1
TCMBANKGE003185 HERC2 D15F37S1; MRT38; SHEP1; jdf2; p528 HECT and RLD domain containing E3 ubiquitin protein ligase 2
TCMBANKGE014110 C3 AHUS5; ARMD9; ASP; C3a; C3b; CPAMD1; HEL-S-62p complement C3
TCMBANKGE004266 AR AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM androgen receptor
TCMBANKGE001158 LEP LEPD; OB; OBS leptin
TCMBANKGE008297 SOX3 GHDX; MRGH; PHP; PHPX; SOXB SRY-box transcription factor 3
TCMBANKGE006669 GAS8 CILD33; DRC4; GAS11 growth arrest specific 8
TCMBANKGE005647 DNAAF2 C14orf104; CILD10; KTU; PF13 dynein axonemal assembly factor 2
TCMBANKGE003019 DNAH1 CILD37; DNAHC1; HDHC7; HL-11; HL11; HSRF-1; SPGF18; XLHSRF-1 dynein axonemal heavy chain 1
TCMBANKGE011882 EHMT2 BAT8; C6orf30; G9A; GAT8; KMT1C; NG36 euchromatic histone lysine methyltransferase 2
TCMBANKGE000811 KL HFTC3 klotho
TCMBANKGE007056 NME8 CILD6; HEL-S-99; NM23-H8; SPTRX2; TXNDC3; sptrx-2 NME/NM23 family member 8
TCMBANKGE006017 SPAG1 CILD28; CT140; HEL-S-268; HSD-3.8; SP75; TPIS sperm associated antigen 1
TCMBANKGE005003 CCNO CCNU; CILD29; UDG2 cyclin O
TCMBANKGE014368 HESX1 ANF; CPHD5; RPX HESX homeobox 1
TCMBANKGE013295 USP8 HumORF8; PITA4; SPG59; UBPY ubiquitin specific peptidase 8
TCMBANKGE007523 TRO MAGE-d3; MAGED3 trophinin
TCMBANKGE001189 IL1A IL-1 alpha; IL-1A; IL1; IL1-ALPHA; IL1F1 interleukin 1 alpha
TCMBANKGE009491 CEP19 C3orf34; MOSPGF centrosomal protein 19
TCMBANKGE003953 ZP3 OOMD3; ZP3A; ZP3B; ZPC; Zp-3 zona pellucida glycoprotein 3
TCMBANKGE000899 GLI2 CJS; HPE9; PHS2; THP1; THP2 GLI family zinc finger 2
TCMBANKGE000931 CYP17A1 CPT7; CYP17; P450C17; S17AH cytochrome P450 family 17 subfamily A member 1
TCMBANKGE003203 LRRC56 CILD39 leucine rich repeat containing 56
TCMBANKGE011872 CDH23 CDHR23; PITA5; USH1D cadherin related 23
TCMBANKGE011389 CFAP251 CaM-IP4; SPGF33; WDR66 cilia and flagella associated protein 251
TCMBANKGE000244 ZMPSTE24 FACE-1; FACE1; HGPS; PRO1; STE24; Ste24p zinc metallopeptidase STE24
TCMBANKGE004382 DNAAF1 CILD13; DAU1; LRRC50; ODA7; swt dynein axonemal assembly factor 1
TCMBANKGE007716 BRDT BRD6; CT9; SPGF21 bromodomain testis associated
TCMBANKGE007692 GSTM1 GST1; GSTM1-1; GSTM1a-1a; GSTM1b-1b; GTH4; GTM1; H-B; MU; MU-1 glutathione S-transferase mu 1
TCMBANKGE004519 SLC26A8 SPGF3; TAT1 solute carrier family 26 member 8
TCMBANKGE010306 FSHB HH24 follicle stimulating hormone subunit beta
TCMBANKGE011581 DNAH5 CILD3; DNAHC5; HL1; KTGNR; PCD dynein axonemal heavy chain 5
TCMBANKGE004396 QRICH2 SPGF35 glutamine rich 2

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇IICP备16009434号-1 | Dai SX Lab